http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. For heart health, you're supposed to know your numbers: Total cholesterol, the bad LDL kind and the good HDL kind. But your next checkup might add a new number to the mix. http://medicalxpress.com/news/2011-10-in-depth-cholesterol.html Health Mon, 24 Oct 2011 18:02:26 EST news238698091 A new study published in the American Journal of Transplantation reveals that substitution of a brand name immunosuppressive drug with a generic (manufactured by Sandoz) for preventing rejection of transplanted organs appears to be safe for transplant recipients. http://medicalxpress.com/news/2011-09-substitution-brand-drug-safe-transplant.html Medications Tue, 13 Sep 2011 11:28:01 EST news235132066 One of the holy grails in diabetes research is to discover molecules that stimulate beta cell growth and to find drugs that target these molecules. Now, JDRF-funded researchers in collaboration with the pharmaceutical company Hoffmann-La Roche, have done both, discovering not only a protein that regulates beta cell growth, but also a chemical compound that stimulates it. The work appears in the September 7 issue of Cell Metabolism. http://medicalxpress.com/news/2011-09-scientists-uncover-ways-pancreatic-beta.html Medical research Tue, 06 Sep 2011 14:48:20 EST news234539287 Shortages of vital drugs, particularly cancer-fighting medication, have raised concerns in the United States, where regulators often have to race to try to find replacements. http://medicalxpress.com/news/2011-09-drug-shortages-mount.html Medications Sun, 04 Sep 2011 04:15:26 EST news234328500 Health Canada is not prevented by law from publicly disclosing safety and efficacy data from clinical trials, pharmaceuticals, biologics and medical devices and should be more transparent, states an analysis in CMAJ (Canadian Medical Association Journal). http://medicalxpress.com/news/2011-08-disclosure-clinical-trial-results-health.html Other Mon, 29 Aug 2011 13:10:29 EST news233842200 In a new study published in Nature Genetics researchers say that women who possess a fault in a gene named RAD51D have a greater risk of developing ovarian cancer than women who do not have this fault and tests are expected to be available within the next few years for those at highest risk, according to Cancer Research UK. http://medicalxpress.com/news/2011-08-faulty-gene-ovarian-cancer.html Cancer Tue, 09 Aug 2011 06:00:01 EST news232073760 Pharmacy benefits manager Express Scripts said Thursday it had reached a deal to buy its competitor Medco Health Systems for $29.1 billion, ahead of looming changes in the US healthcare system. http://medicalxpress.com/news/2011-07-pharmacy-giant-rival-billion.html Medications Thu, 21 Jul 2011 16:21:29 EST news230484079 (AP) -- The head of the United Nations AIDS program called Sunday for an increase in access to drugs that help treat or prevent the spread of the disease, saying it is "morally wrong" to keep millions of people off lifesaving medication. http://medicalxpress.com/news/2011-07-aids-conference-rome.html HIV & AIDS Mon, 18 Jul 2011 06:20:01 EST news230187947 A new research paper sheds light on the way antibodies distinguish between different but closely related 'biomarkers' - proteins which reveal information about the condition of the human body. This new understanding could enable pharmaceutical companies to develop new technologies for quickly diagnosing and treating fatal diseases. http://medicalxpress.com/news/2011-07-biomarkers-earlier-diagnosis-fatal-diseases.html Cancer Fri, 15 Jul 2011 03:29:03 EST news229919318 Yale School of Medicine researchers have found that a clinical trial of the epilepsy drug gabapentin may have been a "seeding trial" used by a pharmaceutical company to promote the drug and increase prescriptions, according to a report in the June issue of Archives of Internal Medicine. http://medicalxpress.com/news/2011-06-clinical-epilepsy-drug-purely.html Medications Mon, 27 Jun 2011 16:00:27 EST news228392997 (Medical Xpress) -- Scientists have voiced their serious concerns over major pharmaceutical companies’ abrupt withdrawal from research into mental illness and neurological diseases. http://medicalxpress.com/news/2011-06-treatments-mental-illness-threat.html Neuroscience Thu, 16 Jun 2011 11:28:47 EST news227442517 Accurate, safe prescribing information for children is often unavailable to doctors in Canada because pharmaceutical companies will not disclose information to Health Canada, states an editorial in CMAJ (Canadian Medical Association Journal). http://medicalxpress.com/news/2011-06-safe-children-canada-hard.html Medications Mon, 13 Jun 2011 13:00:02 EST news227188781 (Medical Xpress) -- A clinical trial for a new technology to diagnose and treat prostate cancer marks the first time Purdue University has directed the entire pathway of a therapeutic product from early research to patient treatment. http://medicalxpress.com/news/2011-06-purdue-prostate-cancer-treatment-concept.html Cancer Thu, 09 Jun 2011 07:02:06 EST news226821416 (Medical Xpress) -- Scientists from the U.S. Food and Drug Administration and the pharmaceutical company Novartis announced today in the journal Science Translational Medicine that they have developed a new adjuvant, or compound that increases the immune response, to add to the current flu vaccines. This adjuvant will allow flu vaccine producers to cut the antigen needed in half and allow for more flu vaccines to be made. This adjuvant would aid in the effectiveness of the flu vaccine while also creating a way to double the U.S. flu vaccine supply. http://medicalxpress.com/news/2011-06-flu-vaccine.html Medications Thu, 02 Jun 2011 07:19:00 EST news226217912 Results demonstrate that 91% of RCTs recording this kind of FCOI achieved a positive - outcome, compared to 66.7% of RCTs without specific FCOI (p=0.02) and adjusting for confounding factors did not change this finding. http://medicalxpress.com/news/2011-05-reveals-financial-conflicts-positive-outcomes.html Other Fri, 27 May 2011 04:45:18 EST news225690301 Government regulators and pharmaceutical companies are moving to address a major new risk for the global supply of medicines: The possibility that unsafe ingredients are entering the supply chain as pharmaceutical companies increasingly outsource the production of drug ingredients to third parties. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine. http://medicalxpress.com/news/2011-05-safety-adulterated-drug-ingredients.html Medications Tue, 17 May 2011 13:05:43 EST news224856326 The Translational Genomics Research Institute (TGen) has licensed its first drug, a unique compound that targets cancer tumors by modifying the actions of proteins. http://medicalxpress.com/news/2011-05-tgen-drug-patient-clinical.html Medications Wed, 04 May 2011 14:48:44 EST news223739298